Drug supply for psoriasis - results from a national pharmacy network
Standard
Drug supply for psoriasis - results from a national pharmacy network. / Franzke, Nadine; Montenbruck, Moritz; Langenbruch, Anna Katharina; Beikert, Florian C; Kresken, Joachim; Augustin, Matthias.
In: J DTSCH DERMATOL GES, Vol. 11, No. 7, 01.07.2013, p. 638-43.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Drug supply for psoriasis - results from a national pharmacy network
AU - Franzke, Nadine
AU - Montenbruck, Moritz
AU - Langenbruch, Anna Katharina
AU - Beikert, Florian C
AU - Kresken, Joachim
AU - Augustin, Matthias
N1 - © The Authors • Journal compilation © Blackwell Verlag GmbH, Berlin.
PY - 2013/7/1
Y1 - 2013/7/1
N2 - BACKGROUND: In Germany, drugs are to a large extent provided by pharmacies. Thus, investigations in pharmacies permit drug usage studies both on patients receiving prescribable drugs and using self-medication. The current study evaluated the quality of medical care, disease burden and spectrum of treatments for patients with psoriasis in a nationwide network of pharmacies.PATIENTS AND METHODS: A nationwide cross-sectional study was conducted in 61 pharmacies. Patients with psoriasis vulgaris who came to the pharmacy to obtain antipsoriatic drugs or basic ointments were consecutively recruited, interviewed and asked to complete a standardized questionnaire. The questionnaire focused on socio-demographic characteristics and prior therapies for psoriasis. Furthermore, data on the patient's treatment satisfaction, disease-related burden, and treatment adherence were evaluated. In addition, the proportion and significance of health care providers for psoriasis as well as the number of patients using self-medication were assessed.RESULTS: The data on 241 patients show a high and long-lasting disease-related burden. A high utilization of resources was found. Dermatologists were the most frequently consulted providers (reported by 77.1 % of patients), followed by general practitioners (10.4 %). 3.5 % of patients were using self-medication. Self-reported adherence with treatment was moderate (71.6 %). Patient satisfaction varied considerably and demonstrated the need for improvement.CONCLUSIONS: Psoriasis is a socio-economically relevant disease. Health care is provided primarily by dermatologists. Surveying patients in a national network of pharmacies is a unique and effective way of collecting relevant "real world" data. Selection biases related to the health care setting are minimized.
AB - BACKGROUND: In Germany, drugs are to a large extent provided by pharmacies. Thus, investigations in pharmacies permit drug usage studies both on patients receiving prescribable drugs and using self-medication. The current study evaluated the quality of medical care, disease burden and spectrum of treatments for patients with psoriasis in a nationwide network of pharmacies.PATIENTS AND METHODS: A nationwide cross-sectional study was conducted in 61 pharmacies. Patients with psoriasis vulgaris who came to the pharmacy to obtain antipsoriatic drugs or basic ointments were consecutively recruited, interviewed and asked to complete a standardized questionnaire. The questionnaire focused on socio-demographic characteristics and prior therapies for psoriasis. Furthermore, data on the patient's treatment satisfaction, disease-related burden, and treatment adherence were evaluated. In addition, the proportion and significance of health care providers for psoriasis as well as the number of patients using self-medication were assessed.RESULTS: The data on 241 patients show a high and long-lasting disease-related burden. A high utilization of resources was found. Dermatologists were the most frequently consulted providers (reported by 77.1 % of patients), followed by general practitioners (10.4 %). 3.5 % of patients were using self-medication. Self-reported adherence with treatment was moderate (71.6 %). Patient satisfaction varied considerably and demonstrated the need for improvement.CONCLUSIONS: Psoriasis is a socio-economically relevant disease. Health care is provided primarily by dermatologists. Surveying patients in a national network of pharmacies is a unique and effective way of collecting relevant "real world" data. Selection biases related to the health care setting are minimized.
KW - Adolescent
KW - Adult
KW - Aged
KW - Aged, 80 and over
KW - Dermatologic Agents
KW - Drug Utilization Review
KW - Employment
KW - Germany
KW - Health Care Surveys
KW - Humans
KW - Medication Adherence
KW - Middle Aged
KW - Patient Satisfaction
KW - Pharmacies
KW - Prescriptions
KW - Prevalence
KW - Psoriasis
KW - Risk Factors
KW - Self Medication
KW - Socioeconomic Factors
KW - Treatment Outcome
KW - Young Adult
U2 - 10.1111/j.1610-0387.2012.08071.x
DO - 10.1111/j.1610-0387.2012.08071.x
M3 - SCORING: Journal article
C2 - 23464851
VL - 11
SP - 638
EP - 643
JO - J DTSCH DERMATOL GES
JF - J DTSCH DERMATOL GES
SN - 1610-0379
IS - 7
ER -